Nesbuvir is a potent and selective inhibitor of the HCV NS5B RNA-dependent RNA polymerase. It demonstrates high antiviral activity in vitro, with an IC50 of 9 nM against HCV genotype 1b replicons in hepatocellular carcinoma cells, supporting its use in hepatitis C virology and antiviral discovery research.